Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery. Enveda's platform is the world's most advanced drug discovery search engine for the expanse of nature's unknown chemistry, building on years of cutting-edge advancements at the intersection of metabolomics and machine learning. Complementing its breakthrough technology, Enveda's team includes seasoned drug hunters with decades of experience in the pharmaceutical industry working with world-leading data scientists.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/21/22	$68,000,000	Series B	Allen & Company Amino Capital FPV Ventures Hummingbird Ventures Jazz Venture Partners Level Ventures Lux Capital Possible Ventures True Ventures Two Sigma Ventures Wireframe Ventures	undisclosed
11/21/24	$130,000,000	Series C	Baillie Gifford Cresset Partners Dimension Capital FPV Ventures Henry Kravis Kinnevik Lingotto Investment Management Lux Capital Premji Invest The Nature Conservancy True Ventures	undisclosed